Document Detail


Use of i.v. immune globulin and occurrence of associated acute renal failure and thrombosis.
MedLine Citation:
PMID:  15790799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
PURPOSE: The use trends of i.v. immune globulin (IGIV) and the frequency of acute renal failure (ARF) and thrombosis at one institution were studied. METHODS: A retrospective chart review on the indications and dosages of IGIV was conducted with inpatients and outpatients at a Veterans Affairs medical center between May 1, 1998, and June 30, 2003. Patients under 18 years of age were excluded from the study. Patient data were obtained through the center's computerized patient record system and included patient demographics, comorbidities, frequency of ARF, concomitant therapies, and IGIV therapy courses. ARF was defined as an increase in serum creatinine of >/=0.5 mg/dL within 10 days from the initiation of IGIV therapy. RESULTS: Forty-six patients were identified as receiving at least one cycle of IGIV therapy between May 1, 1998, and June 30, 2003. The three main indications for IGIV therapy were hypogammaglobulinemia, idiopathic thrombocytopenic purpura (ITP), and chronic inflammatory demyelinating polyneuropathy (CIDP). No new cases of thrombosis were found. Six patients (13%) developed ARF after IGIV administration, but none required dialysis. A greater percentage of patients with ARF were 65 years or older, had chronic renal insufficiency or diabetes mellitus, and used nephrotoxic agents, compared with patients who did not develop ARF. No association was observed between ARF and underlying primary disease. CONCLUSION: A retrospective review of 46 courses of IGIV therapy showed that the therapy was most often used for hematologic, neurologic, and immunologic indications, and the most common diagnoses for which it was used were hypogammaglobulinemia, ITP, and CIDP. ARF developed in 13% of patients, but no case of thrombosis was reported.
Authors:
Sachin Shah; Marne Vervan
Related Documents :
11136169 - Poor long-term survival after coronary angiography in patients with renal insufficiency.
9892379 - Effectiveness of nutrition interventions in the pre-esrd and the esrd population.
3574569 - Spectral analysis of fluctuations in heart rate: an objective evaluation of autonomic n...
8191619 - Beta 2-microglobulin amyloidosis: illustrative cases.
10352219 - 1997 peritoneal dialysis-core indicators study: dialysis adequacy and nutritional indic...
7802519 - Dialysis discontinuation. a 'good' death?
19903669 - A new approach to confirming or excluding ventricular pre-excitation on a 12-lead ecg.
18216399 - Steady-state pharmacokinetics of nevirapine in hiv-1 infected adults in india.
10599659 - Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists     Volume:  62     ISSN:  1079-2082     ISO Abbreviation:  Am J Health Syst Pharm     Publication Date:  2005 Apr 
Date Detail:
Created Date:  2005-03-25     Completed Date:  2005-07-14     Revised Date:  2006-10-13    
Medline Journal Info:
Nlm Unique ID:  9503023     Medline TA:  Am J Health Syst Pharm     Country:  United States    
Other Details:
Languages:  eng     Pagination:  720-5     Citation Subset:  IM    
Affiliation:
School of Pharmacy, Texas Tech University, Dallas/Fort Worth, Dallas, TX 75216, USA. sachin.shah@ttuhsc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Aged
Aged, 80 and over
Hospitals, Veterans
Humans
Immunoglobulins, Intravenous / adverse effects*,  therapeutic use
Kidney Failure, Acute / chemically induced*
Middle Aged
Retrospective Studies
Thrombosis / chemically induced*
Chemical
Reg. No./Substance:
0/Immunoglobulins, Intravenous

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Causes of hyperglycemia and hypoglycemia in adult inpatients.
Next Document:  Patient-assistance programs: assessment of and use by safety-net clinics.